Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» chronic lymphocytic leukemia
chronic lymphocytic leukemia
FDA grants priority review to blood cancer treatment from Pharmacyclics
Yahoo/AP
Thu, 08/29/13 - 09:07 am
FDA
Pharmacyclics
Janssen
JNJ
ibrutinib
mantle cell lymphoma
chronic lymphocytic leukemia
This Small Company Is Winning the War Against Blood Cancer
Motley Fool
Wed, 08/21/13 - 06:59 pm
Pharmacyclics
mantle cell lymphoma
small lymphocytic lymphoma
chronic lymphocytic leukemia
ibrutinib
Expedited Drug Approval May Push Up Pharmacyclics' Value And Stock Price
Seeking Alpha
Mon, 08/12/13 - 05:03 pm
Pharmacyclics
ibrutinib
JNJ
chronic lymphocytic leukemia
mantle cell lymphoma
Breakthrough Status May Spur J&J Drug to Market Early
Bloomberg
Thu, 07/25/13 - 10:42 am
JNJ
breakthrough therapies
ibrutinib
Pharmacyclics
chronic lymphocytic leukemia
mantle cell lymphoma
Roche Says GA101 Beat Rituxan in Test as Replacement Drug
Bloomberg
Wed, 07/24/13 - 09:57 am
Roche
GA101
Rituxan
chronic lymphocytic leukemia
Celgene halts Revlimid ORIGIN trial due to deaths
Yahoo/Fly on the Wall
Thu, 07/18/13 - 09:50 am
clinical trials
Celgene
Revlimid
chronic lymphocytic leukemia
Will This Be the Breakthrough of All Breakthrough Therapy Drugs?
Motley Fool
Thu, 07/11/13 - 11:09 am
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
chronic lymphocytic leukemia
Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Yahoo/AP
Wed, 07/10/13 - 11:05 am
JNJ
Pharmacyclics
ibrutinib
chronic lymphocytic leukemia
FDA grants priority review to Roche's leukemia drug
Reuters
Wed, 07/3/13 - 11:52 am
FDA
Roche
GA101
chronic lymphocytic leukemia
AbbVie announces preliminary results in Phase 1 study of ABT-199
Yahoo/Fly on the Wall
Mon, 06/17/13 - 09:23 am
AbbVie
ABT-199
chronic lymphocytic leukemia
Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in Chronic Lymphocytic Leukemia at ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/2/13 - 11:44 am
IPI-145
Infinity Pharmaceuticals
leukemia
chronic lymphocytic leukemia
Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Forbes
Mon, 05/27/13 - 08:17 pm
Biogen Idec
Rituxan
TG Therapeutics
Utuxin
TGR-1202
CLL
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
The Wild Story Behind A Promising Experimental Cancer Drug
Forbes
Sat, 04/6/13 - 11:04 am
ibrutinib
Pharmacyclics
chronic lymphocytic leukemia
mantle cell lymphoma
JNJ
Abbott to work with J&J on genetic test for leukemia drug
Reuters
Thu, 02/21/13 - 11:52 am
JNJ
Abbott Labs
ibrutinib
chronic lymphocytic leukemia
Roche’s GA101 Met Goals in Stage One of Trial to Replace Rituxan
Bloomberg
Thu, 01/31/13 - 10:41 am
Roche
GA101
Rituxan
chronic lymphocytic leukemia
Pharmacyclics And Promising Advances In Leukemia Treatment
Seeking Alpha
Thu, 12/13/12 - 11:36 am
Pharmacyclics
chronic lymphocytic leukemia
ibrutinib
Pharmacyclics Blood-Cancer Drug Controls Disease in Study
Bloomberg
Sat, 12/8/12 - 11:06 am
chronic lymphocytic leukemia
ibrutinib
Pharmacyclics
Pharmacyclics shares continue climb as analysts project blockbuster sales for cancer drug
Yahoo/AP
Fri, 06/8/12 - 10:06 am
Pharmacyclics
ibrutinib
non-Hodgkin's lymphoma
chronic lymphocytic leukemia
2 Drug Combination Stocks Targeting Leukemia
Seeking Alpha
Wed, 05/23/12 - 12:04 pm
leukemia
Threshold Pharmaceuticals
Pharmacyclics
ibrutinib
chronic lymphocytic leukemia
TH-302
GlaxoSmithKline and Genmab A/S submit NDA to MHLW for Arzerra
Yahoo/Fly on the Wall
Fri, 04/27/12 - 10:18 am
Genmab
GSK
Arzerra
Japan
chronic lymphocytic leukemia
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »